X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (386) 386
humans (292) 292
everolimus-eluting stent (256) 256
male (211) 211
female (206) 206
percutaneous coronary intervention (201) 201
everolimus-eluting stents (199) 199
treatment outcome (189) 189
drug-eluting stents (188) 188
aged (176) 176
middle aged (175) 175
thrombosis (160) 160
stent (138) 138
time factors (115) 115
stents (111) 111
outcomes (105) 105
implantation (104) 104
everolimus (99) 99
sirolimus - analogs & derivatives (97) 97
prosthesis design (95) 95
intervention (94) 94
risk factors (94) 94
cardiovascular (90) 90
revascularization (89) 89
percutaneous coronary intervention - adverse effects (84) 84
follow-up (83) 83
coronary artery disease (82) 82
coronary artery disease - therapy (80) 80
optical coherence tomography (80) 80
sirolimus - administration & dosage (79) 79
percutaneous coronary intervention - instrumentation (76) 76
prospective studies (74) 74
transluminal angioplasty (74) 74
artery-disease (73) 73
coronary heart disease (73) 73
cardiology (71) 71
restenosis (69) 69
drug-eluting stent (68) 68
coronary artery disease - surgery (66) 66
analysis (65) 65
surgery (65) 65
everolimus - administration & dosage (64) 64
follow-up studies (64) 64
mortality (64) 64
trial (64) 64
angioplasty (63) 63
coronary angiography (62) 62
coronary vessels (61) 61
percutaneous coronary intervention - methods (60) 60
bare-metal stents (59) 59
cardiovascular agents - administration & dosage (58) 58
cardiovascular disease (58) 58
metaanalysis (57) 57
abridged index medicus (56) 56
coronary artery disease - mortality (55) 55
care and treatment (54) 54
coronary artery bypass (53) 53
myocardial infarction (53) 53
clinical-outcomes (51) 51
lesions (51) 51
absorbable implants (49) 49
heart attacks (49) 49
stent thrombosis (48) 48
coronary-artery-disease (47) 47
implants (47) 47
patients (46) 46
percutaneous coronary intervention - mortality (46) 46
cardiac patients (45) 45
cardiology and cardiovascular medicine (44) 44
coronary artery disease - diagnostic imaging (43) 43
kaplan-meier estimate (43) 43
bypass-surgery (42) 42
diabetes (42) 42
retrospective studies (41) 41
registries (40) 40
clinical trials (39) 39
paclitaxel-eluting stent (39) 39
coronary artery (38) 38
impact (37) 37
coronary artery disease - diagnosis (36) 36
disease (36) 36
drug-eluting stents - adverse effects (36) 36
medicine & public health (36) 36
risk assessment (36) 36
coronary vessels - diagnostic imaging (35) 35
efficacy (35) 35
myocardial infarction - etiology (35) 35
polymers (35) 35
risk (34) 34
diabetes mellitus (33) 33
patient outcomes (33) 33
surgical implants (33) 33
heart diseases (32) 32
intravascular ultrasound (32) 32
safety (32) 32
acute coronary syndrome (29) 29
medical research (29) 29
randomized controlled trials as topic (29) 29
randomized-trial (29) 29
sirolimus-eluting stent (29) 29
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 14, pp. 1378 - 1386
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2009, Volume 54, Issue 3, pp. 269 - 276
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 14, pp. 1378 - 1386
Journal Article
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2010, Volume 56, Issue 10, pp. S1 - S42
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 03/2016, Volume 5, Issue 3, pp. e003255 - n/a
Background No data are available on the long‐term performance of ultrathin strut biodegradable polymer sirolimus‐eluting stents (BP‐SES). We reported 2... 
drug‐eluting stent | percutaneous coronary intervention | sirolimus‐eluting stent | everolimus‐eluting stent | biodegradable polymer | Sirolimus-eluting stent | Percutaneous coronary intervention | Biodegradable polymer | Everolimus-eluting stent | Drug-eluting stent | LEADERS | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stent | sirolimus-eluting stent | METAANALYSIS | everolimus-eluting stent | BARE METAL STENTS | SAFETY | OUTCOMES | ELEVATION MYOCARDIAL-INFARCTION | Single-Blind Method | Myocardial Infarction - mortality | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Everolimus - administration & dosage | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Time Factors | Everolimus - adverse effects | Female | Odds Ratio | Myocardial Infarction - etiology | Sirolimus - adverse effects | Coronary Thrombosis - mortality | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Linear Models | Treatment Outcome | Coronary Artery Disease - mortality | Chi-Square Distribution | Switzerland | Absorbable Implants | Coronary Angiography | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Polymers - chemistry | Aged | Coronary Thrombosis - etiology | Cardiovascular Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 9, pp. 1180 - 1188
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 5, pp. 867 - 875.e1
.... Our main aim was to evaluate the angiographic efficacy of XIENCE V (everolimus-eluting stent, or EES... 
Cardiovascular | major adverse cardiac events | DSMB | everolimus-eluting stent | myocardial infarction | TLF | TVR | percutaneous coronary intervention | Data Safety Monitoring Board | MACE | stent thrombosis | target vessel revascularization | TLR | CI-TLR | coronary artery bypass grafting | CEC | clinically indicated target lesion revascularization | drug-eluting stent | target lesion revascularization | Academic Research Consortium | ARC | EES | DES | PCI | target lesion failure | CABG | Clinical Events Committee | SURVIVAL | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | CARDIOVASCULAR-DISEASE | RESTENOSIS | END-POINTS | RISK | MELLITUS | OUTCOMES | REGISTRY | Single-Blind Method | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - epidemiology | Angioplasty, Balloon, Coronary - mortality | Statistics, Nonparametric | Female | Everolimus | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Risk Assessment | Taxus | Angioplasty, Balloon, Coronary - methods | Europe | Kaplan-Meier Estimate | Treatment Outcome | Sirolimus - pharmacology | Diabetic Angiopathies - therapy | Coronary Angiography | Diabetes Mellitus, Type 2 - diagnosis | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Asia | Survival Analysis | Diabetic Angiopathies - diagnosis | Diabetic Angiopathies - epidemiology | Aged | Coronary Artery Disease - epidemiology | Diabetes Mellitus, Type 2 - drug therapy | Evaluation Studies as Topic | Transluminal angioplasty | Care and treatment | Diabetes | Research | Coronary artery bypass | Stent (Surgery) | Hypothesis testing | Hypotheses | Heart attacks | Ischemia | Angioplasty | Coronary vessels | Cardiovascular disease | Cardiology | Stents | Thrombosis | Veins & arteries
Journal Article
BMC cardiovascular disorders, ISSN 1471-2261, 2017, Volume 17, Issue 1, p. 84
Journal Article
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2015, Volume 202, pp. 525 - 531
Journal Article